This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Gustav R. Eles, DO; John E. Songer, MD; Donald J. DiPette, MD

Arch Intern Med. 1984;144(6):1296-1297.

Abstract
• The neuroleptic malignant syndrome (NMS), clinically manifested by hyperpyrexia, mental status changes, muscular rigidity, and autonomic dysfunction, is an idiosyncratic reaction to major neuroleptic pharmacologic agents. The reported causes of morbidity and mortality include respiratory insufficiency, cardiovascular collapse, arrhythmias, and renal failure. Coagulopathy does not seem to be a prominent component of the syndrome. We observed a case of NMS in which disseminated intravascular coagulation was a prominent feature.

(Arch Intern Med 1984;144:1296-1297)

Author Affiliations
From the Department of Medicine, Allegheny General Hospital, Pittsburgh.

Footnotes
Accepted for publication July 25, 1983.

Reprint requests to Department of Medicine, Allegheny General Hospital, 320 E North Ave, Pittsburgh, PA 15212 (Dr DiPette).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Sympathoadrenal Hyperactivity and the Etiology of Neuroleptic Malignant Syndrome
Gurrera
Am. J. Psychiatry 1999;156:169-180.
ABSTRACT | FULL TEXT  

Disorders of Temperature Control: Hyperthermia, Part II
Curley and Irwin
J Intensive Care Med 1986;1:91-100.
ABSTRACT